CSF inositol does not predict antidepressant response to inositol

Journal of Neural Transmission

Volumn 103, Issue 12, 1996, Pages 1457-1462

  Levine, J ^a   Kurtzman, L ^a   Rapoport, A ^a   Zimmerman, J ^a   Bersudsky, Y ^a   Shapiro, J ^a   Belmaker, R H ^a,b   Agam, G ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b MENTAL HEALTH CENTER   (Israel)

Author keywords

CSF; Depression; Inositol

Indexed keywords

ANTIDEPRESSANT AGENT; INOSITOL; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFICACY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENSTRUATION DISORDER; PRIORITY JOURNAL; SIDE EFFECT; TACHYCARDIA; VERTIGO;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER; FEMALE; HUMANS; INOSITOL; MALE; MIDDLE AGED; PROGNOSIS;

EID: 0030469480     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01271260     Document Type: Article

References (12)

1. Agam G, Shapiro J, Bersudsky Y, Kofman O, Belmaker RH (1994) Effect of high-dose peripheral inositol: brain inositol levels and prevention of behavioral changes due to inositol depletion. Pharmacol Biochem Behav 49: 341-343
2. Barkai IA, Dunner DL, Gross HA, Mayo P, Fieve RR (1978) Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder. Biol Psychiatry 13: 65-72
3. Bersudsky Y, Shapiro J, Agam G, Kofman O, Belmaker RH (1994) Behavioral evidence for the existence of two pools of cellular inositol. Eur Neuropsychopharmacol 4: 463-467
4. Kofman O, Belmaker RH (1993) Biochemical, behavioral and clinical studies of the role of inositol in lithium treatment and depression. Biol Psychiatry 34: 839-852
5. Levine J, Gonzalves M, Barbam I, Stier S, Elizur A, Kofman O, Belmaker RH (1993a) Inositol 6gm daily may be effective in depression but not in schizophrenia. Hum Psychopharmacol 8: 49-53
6. Levine J, Rapaport A, Lev L, Bersudsky Y, Kofman O, Belmaker RH, Shapiro J, Agam G (1993b) Inositol treatment raises CSF inositol levels. Brain Res 627: 168-170
7. Levine J, Goldberger I, Rapaport A, Schwartz M, Schields C, Elizur A, Belmaker RH, Shapiro J, Agam G (1994) CSF inositol levels in schizophrenia are unchanged and inositol is not therapeutic in anergic schizophrenia. Eur Neuropsychopharmacol 4: 487-490
8. Levine J, Barak Y, Gonsalves M, Szor H, Elizur A, Kofman O, Belmaker RH (1995) A double-blind controlled trial of inositol treatment of depression. Am J Psychiatry 152: 792-794
9. Potter WZ, Manji (1993) Are CSF monoamine metabolites worth measuring? Arch Gen Psychiatry 50: 563-565
10. 2) receptor induced homologous and hetrologous desensitization. Brain Res 631: 349-351
11. Shetty HM, Schapiro MB, Holloway HW, Rapoport SI (1995) Polyol profiles in Down syndrome: myo-inositol specifically, is elevated in the cerebrospinal fluid. Clin Invest 95: 542-546
12. Shimon H, Agam G, Belmaker RH, Hyde T, Kleinman JE (1996) Reduced inositol levels in frontal cortex of post-mortem brain from bipolar patients and suicides. Am J Psychiatry (submitted)